These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20046156)

  • 21. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
    Sheng FF; Dai XP; Qu J; Lei GH; Lu HB; Wu J; Xu XJ; Pei Q; Dong M; Liu YZ; Zhou HH; Liu ZQ
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients.
    Chen L; Liu W; Lai S; Li Y; Wang X; Zhang H
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):935-41. PubMed ID: 23470357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome.
    Trakada G; Steiropoulos P; Nena E; Gkioka T; Kouliatsis G; Pataka A; Sotiriou I; Anevlavis S; Papanas N; Bouros D
    Sleep Breath; 2009 Nov; 13(4):349-55. PubMed ID: 19360446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor-21 and Visfatin as potential predictors for metabolic risk factors in obese children.
    El-Masry SA; Farid MN; Hassan NE; Soliman MA; Mekkawy LH; Elashry GI; Abd El-Fattah SN
    Sci Rep; 2024 Jan; 14(1):1190. PubMed ID: 38216702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus.
    Erdem G; Dogru T; Tasci I; Bozoglu E; Muhsiroglu O; Tapan S; Ercin CN; Sonmez A
    Diabetes Res Clin Pract; 2008 Nov; 82(2):214-8. PubMed ID: 18778865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.
    Marcinkowska M; Lewandowski KC; Lewiński A; Bieńkiewicz M; Basińska-Lewandowska M; Salata I; Randeva HS
    Endokrynol Pol; 2007; 58(3):188-94. PubMed ID: 17940983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy.
    Gong YY; Peng HY
    Lipids Health Dis; 2021 Mar; 20(1):25. PubMed ID: 33722242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.
    Chen CC; Li TC; Li CI; Liu CS; Lin WY; Wu MT; Lai MM; Lin CC
    Metabolism; 2007 Sep; 56(9):1216-20. PubMed ID: 17697864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of β cell function in a Chinese population with different glucose tolerance status.
    Zhou M; Zhu L; Cui X; Feng L; Zhao X; He S; Ping F; Li W; Li Y
    Lipids Health Dis; 2016 Jun; 15():104. PubMed ID: 27267043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance.
    Fernández-Real JM; Moreno JM; Chico B; López-Bermejo A; Ricart W
    Diabetes Care; 2007 Mar; 30(3):616-21. PubMed ID: 17327330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
    Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
    Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
    Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
    Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects.
    Tokunaga A; Miura A; Okauchi Y; Segawa K; Fukuhara A; Okita K; Takahashi M; Funahashi T; Miyagawa J; Shimomura I; Yamagata K
    Endocr J; 2008 Mar; 55(1):205-12. PubMed ID: 18270432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
    Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
    Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids.
    Siahanidou T; Margeli A; Kappis A; Papassotiriou I; Mandyla H
    Metabolism; 2011 Mar; 60(3):389-93. PubMed ID: 20359723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentration of visfatin in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A
    Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.